"On the Cover" — Erratum.
- Published in:
- 2021
- Publication type:
- Correction Notice
Works matching IS 08857156 AND DT 2021 AND VI 36 AND IP 1
Results: 18
1
2
Powder X-ray diffraction of escitalopram oxalate oxalic acid hydrate, (C<sub>20</sub>H<sub>21</sub>FN<sub>2</sub>O)<sub>2</sub>(C<sub>2</sub>O<sub>4</sub>)(H<sub>2</sub>C<sub>2</sub>O<sub>4</sub>)(H<sub>2</sub>O)<sub>0.16</sub>.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 68, doi. 10.1017/S0885715621000026
- By:
- Publication type:
- Article
3
Crystal structure of loteprednol etabonate Form II, C<sub>24</sub>H<sub>31</sub>ClO<sub>7</sub>.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 50, doi. 10.1017/S0885715621000038
- By:
- Publication type:
- Article
4
PDJ volume 36 issue 1 Cover and Back matter.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. b1, doi. 10.1017/S0885715621000154
- Publication type:
- Article
5
Crystal structure of (E)-doxepin hydrochloride, C<sub>19</sub>H<sub>22</sub>NOCl.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 43, doi. 10.1017/S0885715621000063
- By:
- Publication type:
- Article
6
Crystal structure of tezacaftor Form A, C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>O<sub>6</sub>.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 56, doi. 10.1017/S0885715621000051
- By:
- Publication type:
- Article
7
X-ray powder diffraction data of LaNi<sub>0.5</sub>Ti<sub>0.45</sub>Co<sub>0.05</sub>O<sub>3</sub>, LaNi<sub>0.45</sub>Co<sub>0.05</sub>Ti<sub>0.5</sub>O<sub>3</sub>, and LaNi<sub>0.5</sub>Ti<sub>0.5</sub>O<sub>3</sub> perovskites.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 29, doi. 10.1017/S0885715620000767
- By:
- Publication type:
- Article
8
PDJ volume 36 issue 1 Cover and Front matter.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. f1, doi. 10.1017/S0885715621000142
- Publication type:
- Article
9
Editorial.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
10
X-ray powder diffraction data for nicotine 3,5-dihydroxybenzoate dihydrate, C<sub>10</sub>H<sub>15</sub>N<sub>2</sub>⋅C<sub>7</sub>H<sub>5</sub>O<sub>4</sub>⋅2H<sub>2</sub>O.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 25, doi. 10.1017/S0885715621000014
- By:
- Publication type:
- Article
11
Crystal structure of pimecrolimus Form B, C<sub>43</sub>H<sub>68</sub>ClNO<sub>11</sub>.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 35, doi. 10.1017/S088571562100004X
- By:
- Publication type:
- Article
12
Calendar of Short Courses and Workshops.
- Published in:
- 2021
- By:
- Publication type:
- Calendar
13
Observation of multiple Bragg reflections accompanying forbidden Si(002) reflection in bent-perfect Si crystal.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 14, doi. 10.1017/S0885715620000779
- By:
- Publication type:
- Article
14
Crystal structure from laboratory X-ray powder diffraction data, DFT-D calculations, Hirshfeld surface analysis, and energy frameworks of a new polymorph of 1-benzothiophene-2-carboxylic acid.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 2, doi. 10.1017/S0885715620000755
- By:
- Publication type:
- Article
15
Calendar of Forthcoming Meetings.
- Published in:
- 2021
- By:
- Publication type:
- Calendar
16
X-ray powder diffraction data for norethisterone enanthate, C<sub>27</sub>H<sub>38</sub>O<sub>3</sub>.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 65, doi. 10.1017/S0885715620000743
- By:
- Publication type:
- Article
17
Powder diffraction data and preliminary spectroscopic and thermal characterization of pinaverium bromide, a drug used for functional gastrointestinal disorders.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 20, doi. 10.1017/S088571562000072X
- By:
- Publication type:
- Article
18
Powder X-ray diffraction of azelastine hydrochloride, C<sub>22</sub>H<sub>25</sub>ClN<sub>3</sub>O·Cl.
- Published in:
- Powder Diffraction, 2021, v. 36, n. 1, p. 63, doi. 10.1017/S0885715620000664
- By:
- Publication type:
- Article